Lecanemab for Alzheimer's disease: Discussing risks and benefits is key

Medical Xpress

Lecanemab for Alzheimer's disease: Discussing risks and benefits is key

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Canada recently approved lecanemab to treat early Alzheimer's disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex.

An article in the Canadian Medical Association Journal provides an overview of the medication and advises health care professionals to engage in shared decision-making with patients and caregivers to help them understand the potential risks and benefits. ...

전문 보기

Lecanemab for Alzheimer's disease: Discussing risks and benefits is key

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

EXOPLANETS 6

STAT+: AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs

The order of species loss alters how grasslands maintain stability, study finds

Medical Xpress의 다른 기사

Fatal rabies case with no visible wound shows why bat contact alone should trigger immediate vaccination, experts say

Hospital discharge sedatives linked to more falls, readmissions and deaths in older adults

Bones communicate with the rest of the body to support overall health: Here's the science behind your skeleton